• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

35.37 -1.74 (-4.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
August 01, 2023
 
Via Benzinga
News headline image
Omnicell Announces Second Quarter 2023 Results
August 01, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
4 Analysts Have This to Say About Omnicell ↗
July 20, 2023
 
Via Benzinga
News headline image
Top Investment Bank Unveils 3 ETFs, 10 Stocks To Buy In The AI Boom ↗
July 12, 2023
 
Via Benzinga
News headline image
Analyst Expectations for Omnicell's Future ↗
March 01, 2023
 
Via Benzinga
News headline image
Earnings Preview For Omnicell ↗
February 27, 2023
 
Via Benzinga
6 Analysts Have This to Say About Omnicell ↗
January 24, 2023
 
Via Benzinga
News headline image
Why Shares of Omnicell Dropped 33.6% This Week ↗
November 04, 2022
The healthcare medication management company released lowered guidance. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023 ↗
July 20, 2023
 
Via Benzinga
News headline image
Omnicell to Release Second Quarter 2023 Financial Results on August 1, 2023
July 12, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Where Omnicell Stands With Analysts ↗
November 03, 2022
Omnicell (NASDAQ:OMCL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Omnicell Appoints Bobby Ghoshal to Board of Directors
July 11, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Announces Leadership and Organizational Changes
May 30, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Appoints Nchacha E. Etta as Executive Vice President and Chief Financial Officer
May 15, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell to Present at the BofA Securities 2023 Healthcare Conference
May 03, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Announces First Quarter 2023 Results
May 02, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Long Island University and Omnicell Launch Center for Innovative Medication Management
April 20, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell to Release First Quarter 2023 Financial Results on May 2, 2023
April 12, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results
February 28, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Earnings Scheduled For February 28, 2023 ↗
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023 ↗
February 27, 2023
 
Via Benzinga
News headline image
CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 16, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗
January 24, 2023
Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading. 
Via Benzinga
News headline image
Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From Omnicell, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
December 20, 2022
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
News headline image
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
December 05, 2022
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
November 23, 2022
From Omnicell, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022 ↗
November 03, 2022
Upgrades 
Via Benzinga
News headline image
9 Analysts Have This to Say About Omnicell ↗
November 03, 2022
Over the past 3 months, 9 analysts have published their opinion on Omnicell (NASDAQ:OMCL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗
November 03, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap